AUS
NZ
UK
CA
USA
IND
_10_04_2024_16_38_50_427275.jpg)
Key Points:
- Versarien Plc's pipeline of opportunities has surged from £1.6 million to £4.7 million since the appointment of CEO Dr. Stephen Hodge.
- The company remains focused on developing graphene and advanced materials, actively participating in significant R&D initiatives and partnerships.
- Versarien has submitted several grant applications to support its research and development efforts, including a proposal for the Chips Joint Undertaking grant.
Versarien Plc (LSE:VRS), an advanced materials engineering group, has announced encouraging updates regarding its recent developments as the company continues to experience growth in its opportunity pipeline. This positive momentum follows the appointment of Dr. Stephen Hodge as CEO just over a year ago. As of October 1, 2023, Versarien's pipeline stood at £4.7 million, a remarkable increase from the £1.6 million reported earlier. This pipeline comprises commercial opportunities worth £1.6 million and grant opportunities totaling £3.1 million.
The company's ongoing strategy centers on the development of advanced materials, with a particular emphasis on graphene and related technologies. Versarien operates a manufacturing-light business model, focusing on licensing its cutting-edge technology to drive growth and expand its market presence.
Research and Development (R&D) activities at Versarien are progressing steadily. The company's UK R&D teams are actively engaged within renowned institutions such as the Cambridge Graphene Centre at the University of Cambridge and the Nanotechnology and Integrated Bioengineering Centre at Ulster University. Furthermore, Versarien has renewed its Tier 2 partnership with the Graphene Engineering Innovation Centre at the University of Manchester for the sixth consecutive year, reinforcing its commitment to innovation in the field of graphene.
To adapt to the evolving landscape of the European advanced materials ecosystem, Versarien has joined The Innovative Advanced Materials Initiative (IAM-I) as an Industry Member. IAM-I has identified four initial strategic research and innovation priority areas: energy, mobility, construction, and electronics. Dr. Hodge is set to attend Graphene Week 2024 in Prague this month, where he will participate in a panel discussion as part of the Graphene Flagship's REACH/ECHA committee. Engagement in such committees and projects is vital for advancing the commercialization of graphene and other advanced materials.
Grant applications remain a crucial component of Versarien's R&D strategy. In addition to exploring new funding opportunities through its partnership with Gnanomat, the company has submitted a proposal as part of a large consortium for a Chips Joint Undertaking (Chips JU) grant. Moreover, two additional applications for the European Innovation Council's Pathfinder program are currently underway, highlighting Versarien's proactive approach to securing financial support for its innovative projects.
